» Articles » PMID: 11998991

Characterization of Pulmonary Vascular Remodelling in Smokers and Patients with Mild COPD

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2002 May 10
PMID 11998991
Citations 173
Authors
Affiliations
Soon will be listed here.
Abstract

Intimal enlargement of pulmonary arteries is an early change in chronic obstructive pulmonary disease (COPD). The cellular and extracellular components that are involved in this enlargement are unknown. The present study was designed to characterize the structural changes occurring in pulmonary muscular arteries in the initial disease stages. Lung specimens from patients with moderate COPD (n=8; forced expiratory volume in one second (FEV1), 66 +/- 10% predicted) and smokers without airflow obstruction (n=7; FEV1, 86 +/- 6% pred), were investigated by histochemistry to characterize extracellular matrix proteins and by immunohistochemistry to identify intrinsic cells of the vascular wall. In both COPD patients and smokers, the majority of cells present in the enlarged intimas were stained by specific smooth muscle cell (SMC) markers. No staining with endothelial or fibroblast markers was shown. A proportion of SMCs did not stain with desmin, suggesting cellular heterogeneity in this population. Elastin was the most abundant extracellular matrix protein and collagen was seen in a lower proportion. The amount of collagen was related to the intimal thickness (p<0.001). The findings demonstrated smooth muscle cell proliferation, as well as elastin and collagen deposition, in the thickened intimas of pulmonary arteries in moderate chronic obstructive pulmonary disease patients and smokers, suggesting that these abnormalities may originate at an early stage in cigarette smoke-induced respiratory disease.

Citing Articles

Prevalence and Prognostic Value of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.

Mekov E, Yanev N, Kurtelova N, Mihalova T, Tsakova A, Yamakova Y Cureus. 2025; 17(2):e78769.

PMID: 40070614 PMC: 11895804. DOI: 10.7759/cureus.78769.


Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia.

Nakamura K, Akagi S, Ejiri K, Taya S, Saito Y, Kuroda K Int J Mol Sci. 2025; 26(2).

PMID: 39859549 PMC: 11765551. DOI: 10.3390/ijms26020835.


Severe pulmonary hypertension in chronic obstructive pulmonary disease - From clinical perspective to histological evidence.

Zeder K, Sassmann T, Foris V, Douschan P, Olschewski H, Kovacs G Int J Cardiol Congenit Heart Dis. 2024; 17:100519.

PMID: 39711774 PMC: 11658424. DOI: 10.1016/j.ijcchd.2024.100519.


Higher small pulmonary artery and vein volume on computed tomography is associated with mortality in current and former smokers.

Kwee A, Andrinopoulou E, van der Veer T, Gallardo-Estrella L, Charbonnier J, Humphries S EBioMedicine. 2024; 108:105366.

PMID: 39353280 PMC: 11464249. DOI: 10.1016/j.ebiom.2024.105366.


Differentiation and Growth-Arrest-Related lncRNA (): Initial Characterization in Human Smooth Muscle and Fibroblast Cells.

de la Cruz-Thea B, Natali L, Ho-Xuan H, Bruckmann A, Coll-Bonfill N, Strieder N Int J Mol Sci. 2024; 25(17).

PMID: 39273443 PMC: 11394763. DOI: 10.3390/ijms25179497.